ArticleFrontiers in immunology2025

Development of a lung immune prognostic index-based nomogram model for predicting overall survival and immune-related adverse events in non-small cell lung cancer patients treated with sintilimab.

Jian Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.